Login
From:
InnovationMap
(Uncensored)
subscribe
Houston immuno-oncology company reaches next FDA milestone, heads to phase 2 trial - InnovationMap
https://houston.innovationmap.com/diakonos-oncology-fda-jay-hartenbach-2667109142.html
links
backlinks
A Houston immuno-oncology company has recently made major headway with the FDA, including both a fast track and an orphan drug designation. It will soon start a phase 2 trial of its promising cancer fighting innovation.
Roast topics
Find topics
Roast it!
Roast topics
Find topics
Find it!
Roast topics
Find topics
Find it!
